论文信息 - Inotuzumab Ozogamicin (InO) for Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the Global Phase 3 INO-VATE Trial: Efficacy By MLL Status - 字舞流文

Inotuzumab Ozogamicin (InO) for Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the Global Phase 3 INO-VATE Trial: Efficacy By MLL Status

M. Liedtke | H. Kantarjian | E. Jabbour | W. Stock | S. O'brien | A. Advani | E. Vandendries | Jane Liang White | M. Stelljes | A. Laird | N. Goekbuget | Tao Wang